Obicetrapib Alone and with Ezetimibe Reduces Non-HDL-C by Enhanced LDL-Receptor-Mediated VLDL Clearance and Increased Net Fecal Sterol Excretion

Autor: Keijzer, Nanda, Worms, Nicole, van Nieuwkoop, Anita, Ditmarsch, Marc, Jukema, J. Wouter, Groen, Albert, Kastelein, John, Pieterman, Elsbet, Princen, Hans, Inia, José
Zdroj: In Journal of Clinical Lipidology July-August 2024 18(4) Supplement:e552-e552
Databáze: ScienceDirect